title: Cutaneous involvement of marginal zone B-lymphoma noted after topical imiquimod; more than a coincidence?
authors.affiliation: Dermatology Service, Hospital Clinico Lozano Blesa, Zaragoza, Spain.
authors.forename: Tamara
authors.initials: T
authors.lastname: Gracia-Cazaña
authors.forename: Anastasia
authors.initials: A
authors.lastname: Aulés-Leonardo
authors.forename: Miguel Ángel
authors.initials: MÁ
authors.lastname: Marigil-Gómez
authors.forename: Yolanda
authors.initials: Y
authors.lastname: Gilaberte
mesh_terms: D000287:Administration, Topical; D000369:Aged, 80 and over; D000634:Aminoquinolines / Q000008:administration & dosage / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D000077271:Imiquimod; D018442:Lymphoma, B-Cell, Marginal Zone / Q000139:chemically induced* / Q000175:diagnosis*; D008297:Male
chemical_list: D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000077271:Imiquimod